DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT05824585 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Non-Hodgkin

Interventions

DRUG: DZD8586

Sponsor

Dizal Pharmaceuticals